Displaying drugs 5201 - 5225 of 5888 in total
Amrubicin
Amrubicin is a third-generation synthetic anthracycline currently in development for the treatment of small cell lung cancer. Pharmion licensed the rights to Amrubicin in November 2006. In 2002, Amrubicin was approved and launched for sale in Japan based on Phase 2 efficacy data in both SCLC and NSCLC. Since January...
Investigational
Medical Cannabis
The use of the plant species Cannabis sativa and Cannabis indica, popularly known as marijuana, has gained popularity in recent years for the management of a wide variety of medical conditions as a wave of legalization in North America has changed public and medical opinion on its use. Consequently, an...
Experimental
Investigational
Matched Description: … These effects are largely mediated through two members of the G-protein coupled receptor family, cannabinoid ... shown to act as a negative allosteric modulator of the cannabinoid CB1 receptor, the most abundant G-Protein …
Gandotinib
Gandotinib has been used in trials studying the treatment of Myelofibrosis, Polycythemia Vera, Primary Myelofibrosis, Thrombocythemia, Essential, and Myeloproliferative Disorders, among others.
Investigational
Quabodepistat
Investigational
ABSK-012
Investigational
PRX-08066
Investigational
Belvarafenib
Investigational
Methoxy arachidonyl fluorophosphonate
Methoxy arachidonyl fluorophosphonate, commonly referred as MAFP, is an irreversible active site-directed enzyme inhibitor that inhibits nearly all serine hydrolases and serine proteases. It inhibits phospholipase A2 and fatty acid amide hydrolase with special potency, displaying IC50 values in the low-nanomolar range.
Experimental
5-Formyl-2'-deoxy-cytidine-5'-monophosphate
Experimental
5-[2-(TRIFLUOROMETHOXY)PHENYL]-2-FUROIC ACID
Experimental
ORTHONITROPHENYL-BETA-D-FUCOPYRANOSIDE
Experimental
G4460
Investigational
Hesperetin
Hesperetin belongs to the flavanone class of flavonoids. Hesperetin, in the form of its glycoside hesperidin, is the predominant flavonoid in lemons and oranges.
Experimental
5-(2-Chlorophenyl)Furan-2-Carboxylic Acid
Experimental
2'-fluoro-2'-deoxyuridine 3'-monophosphate
Experimental
5-[2-(TRIFLUOROMETHYL)PHENYL]-2-FUROIC ACID
Experimental
5-(2-chlorophenyl)furan-2-carbohydrazide
Experimental
Cilofexor
Cilofexor is under investigation in clinical trial NCT02943447 (Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Biliary Cholangitis Without Cirrhosis).
Investigational
Batroxobin
Batroxobin is a defibrinogenating hemostatic agent derived from the venom of a pit viper, Bothrops atrox moojeni. In addition to batroxobin, the venom of Bothrops atrox has a composition of 10.2% neutral carbohydrate. Batroxobin is a serine protease, which cleaves the 16 Arginine - 17 Glycine bond in fibrinogen. The...
Experimental
Matched Description: … Recombinant Batroxobin in relatively affordable and could be accessed by mass production. …
WP-1066
WP1066 has been used in trials studying the treatment of Melanoma, Brain Cancer, Solid Tumors, and Central Nervous System Neoplasms.
Investigational
OMS906
OMS906 is a humanized Igg4 monoclonal antibody against mannan-binding lectin-associated serine protease-3 (MASP-3) currently being developed by Omeros.
Investigational
2-(3-BENZOYLPHENOXY)ETHYL(HYDROXY)FORMAMIDE
Experimental
Displaying drugs 5201 - 5225 of 5888 in total